Harrow (HROW) Capital Expenditures (2012 - 2026)

Harrow (HROW) recorded quarterly Capital Expenditures of $194000.0 in Q1 2026, down 43.11% quarter-over-quarter from $341000.0 in Q4 2025, and up 14.12% on a YoY basis from $170000.0 in Q1 2025.

Harrow (HROW) Capital Expenditures (2012 - 2026) Analysis & Trends

Harrow's Capital Expenditures history runs 15 years deep, the most recent figure standing at $194000.0 for Q1 2026.

  • In Q1 2026, Capital Expenditures rose 14.12% year-over-year to $194000.0; the TTM figure through Mar 2026 stood at $911000.0 (up 472.96% YoY), while the FY2025 annual figure was $887000.0, up 995.06% from the prior year.
  • Capital Expenditures was $194000.0 for Q1 2026 at Harrow, down from $341000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $1.2 million in Q3 2023 to a low of -$959000.0 in Q4 2024.
  • Historically, Capital Expenditures has averaged $307000.0 across 5 years, with a median of $260000.0 in 2022.
  • The sharpest annual moves came in 2022 and 2024: Capital Expenditures surged 540.88% in 2022, then sank 594.33% in 2024.
  • A 5-year view of Capital Expenditures shows it stood at $878000.0 in 2022, then tumbled by 77.9% to $194000.0 in 2023, then tumbled by 594.33% to -$959000.0 in 2024, then soared by 135.56% to $341000.0 in 2025, then tumbled by 43.11% to $194000.0 in 2026.
  • The last three Capital Expenditures figures came in at $194000.0 (Q1 2026), $341000.0 (Q4 2025), and $210000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 168.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 110.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 100.80 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 9.10 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 51.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 4.09 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 8.83 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 2.04 Mn
10 Harrow 1.25 Bn 1.15 Bn 27.05 Mn 194,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 194,000.00
Mar 31, 2026 194,000.00
Dec 31, 2025 341,000.00
Dec 31, 2025 341,000.00
Sep 30, 2025 210,000.00
Sep 30, 2025 210,000.00
Jun 30, 2025 166,000.00
Jun 30, 2025 166,000.00
Mar 31, 2025 170,000.00
Mar 31, 2025 170,000.00
Dec 31, 2024 -959,000.00
Dec 31, 2024 -959,000.00
Sep 30, 2024 604,000.00
Sep 30, 2024 604,000.00
Jun 30, 2024 344,000.00
Jun 30, 2024 344,000.00
Mar 31, 2024 92,000.00
Mar 31, 2024 92,000.00
Dec 31, 2023 194,000.00
Dec 31, 2023 194,000.00